A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
D000818:Animals; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D051379:Mice; D008920:Misonidazole / Q000627:therapeutic use*; D009374:Neoplasms, Experimental / Q000532:radiotherapy*; D009593:Nitroimidazoles / Q000627:therapeutic use*; D010100:Oxygen; D011879:Radiotherapy Dosage; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy
D009593:Nitroimidazoles; D008920:Misonidazole; D010100:Oxygen